Steward Partners Investment Advisory’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $356K | Sell |
4,131
-3,696
| -47% | -$324K | ﹤0.01% | 1910 |
|
|
2026
Q1 | $708K | Buy |
7,827
+2,106
| +37% | +$193K | ﹤0.01% | 1337 |
|
|
2025
Q4 | $514K | Sell |
5,721
-45
| -0.8% | -$4.27K | ﹤0.01% | 1405 |
|
|
2025
Q3 | $568K | Buy |
5,766
+220
| +4% | +$21.8K | ﹤0.01% | 1304 |
|
|
2025
Q2 | $506K | Sell |
5,546
-2,496
| -31% | -$241K | ﹤0.01% | 1295 |
|
|
2025
Q1 | $910K | Sell |
8,042
-300
| -4% | -$32.1K | 0.01% | 956 |
|
|
2024
Q4 | $881K | Sell |
8,342
-10,457
| -56% | -$1.12M | 0.01% | 922 |
|
|
2024
Q3 | $2.03M | Buy |
18,799
+1,192
| +7% | +$130K | 0.02% | 624 |
|
|
2024
Q2 | $1.91M | Sell |
17,607
-24
| -0.1% | -$2.83K | 0.02% | 598 |
|
|
2024
Q1 | $2.33M | Buy |
17,631
+929
| +6% | +$116K | 0.03% | 533 |
|
|
2023
Q4 | $2.03M | Buy |
16,702
+121
| +0.7% | +$13.5K | 0.03% | 502 |
|
|
2023
Q3 | $1.86M | Buy |
16,581
+1,019
| +7% | +$129K | 0.03% | 491 |
|
|
2023
Q2 | $2.27M | Buy |
15,562
+1,322
| +9% | +$180K | 0.03% | 443 |
|
|
2023
Q1 | $1.84M | Sell |
14,240
-81
| -0.6% | -$10.2K | 0.03% | 482 |
|
|
2022
Q4 | $1.83M | Buy |
14,321
+1
| +0% | +$116 | 0.03% | 479 |
|
|
2022
Q3 | $1.5M | Buy |
14,320
+244
| +2% | +$26.8K | 0.03% | 513 |
|
|
2022
Q2 | $1.48M | Sell |
14,076
-89
| -0.6% | -$10.6K | 0.03% | 523 |
|
|
2022
Q1 | $1.81M | Buy |
14,165
+454
| +3% | +$54.7K | 0.03% | 508 |
|
|
2021
Q4 | $1.69M | Buy |
13,711
+171
| +1% | +$22.4K | 0.03% | 538 |
|
|
2021
Q3 | $1.92M | Buy |
13,540
+810
| +6% | +$119K | 0.03% | 467 |
|
|
2021
Q2 | $1.99M | Sell |
12,730
-1,044
| -8% | -$169K | 0.03% | 445 |
|
|
2021
Q1 | $2.14M | Buy |
13,774
+1,277
| +10% | +$198K | 0.04% | 416 |
|
|
2020
Q4 | $1.87M | Sell |
12,497
-795
| -6% | -$112K | 0.04% | 379 |
|
|
2020
Q3 | $1.76M | Buy |
13,292
+156
| +1% | +$20.4K | 0.04% | 348 |
|
|
2020
Q2 | $1.52M | Buy |
13,136
+790
| +6% | +$91K | 0.04% | 357 |
|
|
2020
Q1 | $1.21M | Buy |
12,346
+9,571
| +345% | +$1.25M | 0.04% | 343 |
|
|
2019
Q4 | $403K | Buy |
2,775
+634
| +30% | +$87.5K | 0.01% | 681 |
|
|
2019
Q3 | $285K | Sell |
2,141
-58
| -3% | -$7.49K | 0.01% | 738 |
|
|
2019
Q2 | $251K | Buy |
2,199
+238
| +12% | +$27.9K | 0.01% | 747 |
|
|
2019
Q1 | $243K | Sell |
1,961
-400
| -17% | -$45.5K | 0.01% | 691 |
|
|
2018
Q4 | $237K | Sell |
2,361
-151
| -6% | -$17K | 0.01% | 658 |
|
|
2018
Q3 | $321K | Buy |
2,512
+1,104
| +78% | +$131K | 0.02% | 606 |
|
|
2018
Q2 | $152K | Buy |
1,408
+335
| +31% | +$36.5K | 0.01% | 731 |
|
|
2018
Q1 | $113K | Buy |
1,073
+10
| +0.9% | +$1.16K | 0.01% | 744 |
|
|
2017
Q4 | $124K | Sell |
1,063
-171
| -14% | -$19.3K | 0.01% | 609 |
|
|
2017
Q3 | $140K | Buy |
1,234
+368
| +42% | +$42.5K | 0.01% | 491 |
|
|
2017
Q2 | $107K | Sell |
866
-2,336
| -73% | -$277K | 0.01% | 488 |
|
|
2017
Q1 | $379K | Buy |
3,202
+924
| +41% | +$105K | 0.06% | 232 |
|
|
2016
Q4 | $228K | Buy |
+2,278
| New | +$244K | 0.1% | 165 |
|
Other funds holding ZBH
Steward Partners Investment Advisory's ZBH Position: Q2 2026 in Review
Steward Partners Investment Advisory reduced its Zimmer Biomet (ZBH) stake by 47% in Q2 2026, selling an estimated $324K and leaving 4,131 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.
Steward Partners Investment Advisory first reported a position in ZBH in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.33M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Steward Partners Investment Advisory held 4,131 shares of Zimmer Biomet worth $356K as of Q2 2026.
- Steward Partners Investment Advisory sold 3,696 Zimmer Biomet shares in Q2 2026, an estimated $324K.
- Zimmer Biomet made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1910 holding.
- Steward Partners Investment Advisory first reported a position in Zimmer Biomet in Q4 2016 and has held it in 39 quarters since.
- Steward Partners Investment Advisory's Zimmer Biomet position peaked at $2.33M in Q1 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.